GlassScriptPhysician profile
Bhupinder Anand
NPI 1861441933
$8,540.88
in general payments reported to CMS, 2019-2025
55 companies · $875 in 2025
The $875 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,651 · 2020: $268 · 2021: $1,580 · 2022: $2,912 · 2023: $1,238 · 2024: $15.68 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,071.66 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Ucb, INC. | $933.26 | 2019-2025 | Rystiggo, Briviact |
| Neurocrine Biosciences, INC. | $584.10 | 2020-2023 | Ongentys, Ingrezza |
| Sk Life Science, INC. | $560.80 | 2021-2023 | Xcopri |
| Acorda Therapeutics, INC | $378.43 | 2019-2023 | Inbrija |
| Eisai INC. | $365.83 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $364.62 | 2019-2022 | |
| Greenwich Biosciences, INC. | $358.96 | 2019-2021 | |
| Amgen INC. | $326.76 | 2019-2022 | |
| Boston Scientific Corporation | $285.93 | 2023 | Watchman Access System, Watchman Flx |
| Allergan, INC. | $266.24 | 2019-2022 | |
| Lundbeck LLC | $248.81 | 2019-2025 | Vyepti, Rexulti |
| Emd Serono, INC. | $227.83 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $212.59 | 2019-2023 | Nuplazid |
| Livanova USA, INC. | $208.64 | 2019-2020 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhupinder Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.